This HTML5 document contains 97 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n5http://dx.doi.org/10.1016/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n9http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q82658512
rdf:type
wikibase:Item
schema:description
наукова стаття, опублікована в жовтні 2011 wetenschappelijk artikel im Oktober 2011 veröffentlichter wissenschaftlicher Artikel scientific article published on 29 October 2011 artículu científicu espublizáu n'ochobre de 2011 article scientifique publié en 2011
p:P577
wds:Q82658512-3EFC5C2A-9757-41B3-8922-B2CB1E4C3735
wdt:P577
2011-10-29T00:00:00Z
p:P2860
wds:Q82658512-0471C00F-C2FD-4BF6-A28E-B95F6C47885F wds:Q82658512-078417E1-08CD-4040-B738-DA07ADC1958A wds:Q82658512-25F460F5-A91D-43F0-A67B-CD3223769E69 wds:Q82658512-2D8D63B5-2044-42E5-8076-DE9AFF53D08C wds:Q82658512-34946643-77D8-460F-8D7B-06AD1EF139BE wds:Q82658512-20446ABC-9B48-48FC-908E-CF7B33E80B0B wds:Q82658512-452C3069-165B-4A1B-8525-6E3FE3B90B4B wds:Q82658512-3F3035F9-7495-4503-936E-522A7F1203E3 wds:Q82658512-64B03879-472D-4B6B-A04E-C8576714BCB3 wds:Q82658512-6A93869B-308F-4DB0-AC91-25D968ED9AE7 wds:Q82658512-882DD8C6-17B7-49E2-A57A-A9A10EA36D04 wds:Q82658512-48498050-AF85-48B0-ADF6-A09B490E4F7D wds:Q82658512-59BEC64D-7CB5-4EE7-8C70-2A81DEC00F43 wds:Q82658512-59FC99C4-437B-4C68-A516-1C6D662616A3 wds:Q82658512-C245115B-A330-43AE-8E02-FAD686C60D1F wds:Q82658512-C787C8C5-156D-4300-B615-BC82279294BF wds:Q82658512-89550339-24CE-462F-BA14-346244622F70 wds:Q82658512-A312BB01-9CF8-4AF9-A406-67D5CB56C3A0 wds:Q82658512-E4D7C101-6E06-416C-BC22-9C70286D1CA2 wds:Q82658512-E835751F-34A3-46E2-9426-6054E7B28169 wds:Q82658512-D79FF9A6-E153-4FED-BC20-C60F58F67E45 wds:Q82658512-DF2D5A52-95B6-46DA-B9F6-A380750AD9F9
wdt:P2860
wd:Q33918965 wd:Q42576797 wd:Q37695699 wd:Q48300047 wd:Q34396098 wd:Q51782640 wd:Q51900571 wd:Q36859872 wd:Q46147035 wd:Q37390118 wd:Q34001615 wd:Q34956532 wd:Q80366170 wd:Q27759564 wd:Q44957001 wd:Q44730873 wd:Q46952232 wd:Q34043025 wd:Q46805938 wd:Q34386181 wd:Q31944578 wd:Q46883847
p:P2093
wds:Q82658512-D2E285BA-8C3B-4731-A7C1-2FE9FF28AD4F wds:Q82658512-B2A0899D-E895-40F7-BF18-C4B11965CD07 wds:Q82658512-EAF9AB6A-4AF1-4F4A-86C2-EB02523DF14B wds:Q82658512-45996423-B827-41F8-B0B5-BB9AA03F4E50 wds:Q82658512-45B1E28C-6DC0-4C80-B287-C292751961A4 wds:Q82658512-45384B8F-27D3-4847-BB25-32E3ABD213E7 wds:Q82658512-1FDBC651-67F6-4C47-9A96-672EB4FDC93D
wdt:P2093
Dorothy Markowitz David Erickson Cindy Pham Lorentz Kyle D Rudser Jeanine R Jarnes Utz Chester B Whitley Brenda Diethelm-Okita
rdfs:label
START, a double blind, placebo-controlled pharmacogenetic test of responsiveness to sapropterin dihydrochloride in phenylketonuria patients START, a double blind, placebo-controlled pharmacogenetic test of responsiveness to sapropterin dihydrochloride in phenylketonuria patients
skos:prefLabel
START, a double blind, placebo-controlled pharmacogenetic test of responsiveness to sapropterin dihydrochloride in phenylketonuria patients START, a double blind, placebo-controlled pharmacogenetic test of responsiveness to sapropterin dihydrochloride in phenylketonuria patients
schema:name
START, a double blind, placebo-controlled pharmacogenetic test of responsiveness to sapropterin dihydrochloride in phenylketonuria patients START, a double blind, placebo-controlled pharmacogenetic test of responsiveness to sapropterin dihydrochloride in phenylketonuria patients
p:P1476
wds:Q82658512-7D76895A-39B3-4224-9E0C-B71DD6789FDE
wdt:P1476
START, a double blind, placebo-controlled pharmacogenetic test of responsiveness to sapropterin dihydrochloride in phenylketonuria patients
p:P304
wds:Q82658512-4F8FCE95-FE91-4EE3-8A91-AE600D5EF292
wdt:P304
193-197
p:P31
wds:Q82658512-D68157F3-6618-4076-AED4-975B5D63F402
wdt:P31
wd:Q13442814
p:P921
wds:Q82658512-34FAB773-B468-4DD8-A2D7-AEE14447F38F wds:Q82658512-3AC1CB76-3DF4-4F48-BB32-FA11DDDCA8A7 wds:Q82658512-E3F83101-A78A-43D2-AA6C-2441AF08AB58
wdt:P921
wd:Q269829 wd:Q27114793 wd:Q419808
p:P698
wds:Q82658512-22681BFA-B112-47CE-8276-EE2A0541D47D
wdtn:P698
n9:22112818
wdt:P698
22112818
p:P1433
wds:Q82658512-8CB23BB2-4EE6-4102-8075-ADBB9BA8A174
wdt:P1433
wd:Q6895949
p:P433
wds:Q82658512-8ABA795A-E2DD-40DF-B1B3-0AEAA7C71F28
p:P478
wds:Q82658512-1A09E148-B71C-443F-ADCE-49D3B8FE63C0
wdt:P433
2
wdt:P478
105
p:P356
wds:Q82658512-176A2F35-ACFF-484C-B02E-A8003ED411B3
wdtn:P356
n5:J.YMGME.2011.10.014
wdt:P356
10.1016/J.YMGME.2011.10.014